vutrisiran
General
Pronunciation:
vue-tri-sir-an
Trade Name(s)
- Amvuttra
Ther. Class.
none assigned
Pharm. Class.
antitransthyretin small interfering rnas
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Vutrisiran." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580113/9/vutrisiran.
Vallerand AHA, Sanoski CAC, . Vutrisiran. Davis's Drug Guide. F.A. Davis Company; 2025. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580113/9/vutrisiran. Accessed April 24, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Vutrisiran. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580113/9/vutrisiran
Vallerand AHA, Sanoski CAC, . Vutrisiran [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 April 24]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580113/9/vutrisiran.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - vutrisiran
ID - 3580113
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580113/9/vutrisiran
PB - F.A. Davis Company
ET - 19
DB - Nursing Central
DP - Unbound Medicine
ER -